Home › Glioblastoma › Ohio › Columbus
Glioblastoma clinical trials in Columbus, OH
14 studies for Glioblastoma are looking for participants at sites in and around Columbus (within about 30 miles). Open a study to see who can join and how to contact the study team.
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
RecruitingPhase 1/2
- Ohio State University Comprehensive Cancer Center, Columbus
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
RecruitingPhase 2
- Ohio State University, Columbus
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
RecruitingPhase 3
- The Ohio State University, Columbus
Targeted Pediatric High-Grade Glioma Therapy
RecruitingObservational study
- Nationwide Children's Hospital, Columbus
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
RecruitingPhase 1
- Ohio State University Comprehensive Cancer Center, Columbus
Study of Olutasidenib and Temozolomide in HGG
RecruitingPhase 2
- Nationwide Children's Hospital, Columbus
Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma
Recruiting
- Ohio State University Medical Center, Columbus
Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma
RecruitingPhase 2
- Ohio State University, Columbus
DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
RecruitingPhase 2
- The Ohio State University Comprehensive Cancer Center, Columbus
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
RecruitingEarly phase 1Healthy volunteers welcome
- Nationwide Children's Hospital, Columbus
Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma
RecruitingPhase 1/2
- Ohio State University Hospital, Columbus
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
RecruitingPhase 2
- Nationwide Children's Hospital, Columbus
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
RecruitingPhase 1/2
- Ohio State University Comprehensive Cancer Center, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Columbus
Glioblastoma trials in other cities
- New York City, NY30 studies
- Boston, MA29 studies
- Houston, TX25 studies
- Los Angeles, CA22 studies
- Durham, NC20 studies
- San Francisco, CA18 studies
- Rochester, MN15 studies
- Chicago, IL15 studies
- Washington, DC15 studies
- Miami, FL14 studies
- Jacksonville, FL13 studies
- Aurora, CO12 studies
Other studies in Columbus
- Non-Small Cell Lung Cancer55 studies
- Cancer (all types)39 studies
- Breast Cancer39 studies
- Ovarian Cancer39 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Chronic Lymphocytic Leukemia29 studies
- Metastatic Cancer27 studies
- Endometrial Cancer26 studies
- Colorectal Cancer24 studies
- Multiple Myeloma24 studies
- Prostate Cancer24 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.